Mohammad hojjat-farsangi
Karolinska Institutet
H-index: 37
Europe-Sweden
Top articles of Mohammad hojjat-farsangi
Title | Journal | Author(s) | Publication Date |
---|---|---|---|
The sensitivity of acute myeloid leukemia cells to cytarabine is increased by suppressing the expression of Heme oxygenase-1 and Hypoxia-inducible factor 1-alpha | Mohammad Sadeghi Asma Moslehi Hadiseh Kheiry Fariba Karoon Kiani Atefeh Khodakarami | 2024/1/31 | |
The role of exhausted natural killer cells in the immunopathogenesis and treatment of leukemia | Asal Barshidi Keivan Ardeshiri Farbod Ebrahimi Fatemeh Alian Ali Akbar Shekarchi | 2024/1/22 | |
Retraction Note: Dual Blockade of PD-1 and LAG3 Immune Checkpoints Increases Dendritic Cell Vaccine Mediated T Cell Responses in Breast Cancer Model | Pharmaceutical research | Asal Barshidi Vahid Karpisheh Fatemeh Karimian Noukabadi Fariba Karoon Kiani Mohammad Mohammadi | 2024/2 |
Silencing interleukin-6 and glycoprotein 130 suppresses growth and induces apoptosis in cancer cells | International Journal of Drug Research in Clinics | Parastoo Khodayari Atefeh Khodakarami Hadi Hassannia Ghasem Ghalamfarsa Mohammad Hojjat-Farsangi | 2023/5/17 |
Detection of receptor tyrosine kinase-orphan receptor-2 using an electrochemical immunosensor modified with electrospun nanofibers comprising polyvinylpyrrolidone, soy, and … | Microchimica Acta | Fatemeh Maleki Habib Razmi Mohammad-Reza Rashidi Mehdi Yousefi Soghra Ramazani | 2023/10 |
The role of SF3B1 and NOTCH1 in the pathogenesis of leukemia | Shiva Abolhasani Seyyed Sina Hejazian Vahid Karpisheh Atefeh Khodakarami Hamed Mohammadi | 2023/3 | |
Corrigendum to" Silencing adenosine A2a receptor enhances dendritic cell-based cancer immunotherapy"[Nanomedicine Nanotechnol Biol Med 29 (2020) 102240] | Nanomedicine: nanotechnology, biology, and medicine | Ali Masjedi Armin Ahmadi Sepideh Ghanee Farinaz Malakotikhah Mohsen Nabi Afjadi | 2023/5/9 |
Codelivery of Nrf 2 siRNA and Cyclophosphamide Inhibits Leukemia Progression | Atefeh Khodakarami Mahsa Afsari Kashani Atefeh Nazer Armin Mahmoudsalehi Kheshti Bentolhoda Rashidi | 2023/8/2 | |
Blockade of CD155 and interleukin-6 suppresses breast cancer cell growth | International Journal | Atefeh Khodakarami Samira Darvishi Hadi Hassannia Mohammad Sadeghi Sana Esmaeeli | 2023 |
A small molecule targeting the intracellular tyrosine kinase domain of ROR1 (KAN0441571C) induced significant apoptosis of non-small cell lung cancer (NSCLC) Cells | Pharmaceutics | Amineh Ghaderi Mohammad-Ali Okhovat Jemina Lehto Luigi De Petris Ehsan Manouchehri Doulabi | 2023/4/5 |
Targeted Silencing of NRF2 by rituximab-conjugated nanoparticles increases the sensitivity of chronic lymphoblastic leukemia cells to Cyclophosphamide | Cell Communication and Signaling | Atefeh Khodakarami Mahsa Afsari Kashani Atefeh Nazer Armin Mahmoudsalehi Kheshti Bentolhoda Rashidi | 2023/8/1 |
Dual Blockade of PD-1 and LAG3 Immune Checkpoints Increases Dendritic Cell Vaccine Mediated T Cell Responses in Breast Cancer Model (Retraction of Vol 39, Pg 1851, 2022) | Pharmaceutical research | Asal Barshidi Vahid Karpisheh Fatemeh Karimian Noukabadi Fariba Karoon Kiani Mohammad Mohammadi | 2022/8 |
Preeclampsia-derived exosomes imbalance the activity of Th17 and Treg in PBMCs from healthy pregnant women | Reproductive Sciences | Ramin Pourakbari Forough Parhizkar Mohammad Sadegh Soltani‐Zangbar Parisa Samadi Majid Zamani | 2023/4 |
Evaluation of the anti-tumor effects of an anti-Human Epidermal growth factor receptor 2 (HER2) monoclonal antibody in combination with CD11b+/Gr-1+ myeloid cells depletion … | International Immunopharmacology | Khadijeh Ramezani-Aliakbari Vahid Khaki-Bakhtiarvand Jafar Mahmoudian Hossein Asgarian-Omran Fazel Shokri | 2023/8/1 |
A CX3CR1 (fractalkine receptor) Small Molecular Antagonist (KAND567) Suppressed the Growth Promoting Effect of Monocytes on Chronic Lymphocytic Leukemia Cells | Blood | Mohammad Hojjat-Farsangi Wen Zhong Tom Mulder Ann Svensson Jeanette Lundin | 2023/11/28 |
Pan Cyclin-Dependent Kinase Inhibitors for the Treatment of Breast Cancer | Sepideh Izadi Mohammad Hojjat-Farsangi Vahid Karpisheh Farhad Jadidi-Niaragh | 2023/3/15 | |
Establishment of a murine model of breast cancer expressing human epidermal growth factor receptor 2 (4T1-HER2) | Journal of Cancer Research and Therapeutics | Vahid Khaki Bakhtiarvand Khadijeh Ramezani-Ali Akbari Fatemeh Sadri Farzaneh Notash Haghighat Mohammad Hojjat-Farsangi | 2023/7/19 |
IGF1R and HIF-1α Gene Silencing Inhibits Cancer Cell Growth | International Journal of Drug Research in Clinics | Shiva Abolhasani Sepideh Javadi Hadi Hassannia Ghasem Ghalamfarsa Mohammad Hojjat-Farsangi | 2023/11/7 |
The prognostic and therapeutic potential of HO-1 in leukemia and MDS | Mohammad Sadeghi Mehrdad Fathi Jamshid Gholizadeh Navashenaq Hamed Mohammadi Mehdi Yousefi | 2023/3/13 | |
Application of emerging plant-derived nanoparticles as a novel approach for nano-drug delivery systems | Immunological investigations | Parisa Sarvarian Parisa Samadi Elham Gholipour Karim Shams Asenjan Mohammad Hojjat-Farsangi | 2022/5/19 |